MX2010011063A - Tratamiento esteroidal para sofocos. - Google Patents

Tratamiento esteroidal para sofocos.

Info

Publication number
MX2010011063A
MX2010011063A MX2010011063A MX2010011063A MX2010011063A MX 2010011063 A MX2010011063 A MX 2010011063A MX 2010011063 A MX2010011063 A MX 2010011063A MX 2010011063 A MX2010011063 A MX 2010011063A MX 2010011063 A MX2010011063 A MX 2010011063A
Authority
MX
Mexico
Prior art keywords
male
estra
individual
agent
administered
Prior art date
Application number
MX2010011063A
Other languages
English (en)
Spanish (es)
Inventor
Louis Monti
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of MX2010011063A publication Critical patent/MX2010011063A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
MX2010011063A 2008-04-09 2009-04-09 Tratamiento esteroidal para sofocos. MX2010011063A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
PCT/US2009/040102 WO2009126825A1 (en) 2008-04-09 2009-04-09 Steroid treatment for hot flashes

Publications (1)

Publication Number Publication Date
MX2010011063A true MX2010011063A (es) 2010-11-22

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010011063A MX2010011063A (es) 2008-04-09 2009-04-09 Tratamiento esteroidal para sofocos.

Country Status (10)

Country Link
US (2) US20090258040A1 (cg-RX-API-DMAC10.html)
EP (1) EP2278880B1 (cg-RX-API-DMAC10.html)
JP (1) JP5524177B2 (cg-RX-API-DMAC10.html)
KR (1) KR101602802B1 (cg-RX-API-DMAC10.html)
CN (1) CN102056484B (cg-RX-API-DMAC10.html)
AU (1) AU2009234159B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0910637A2 (cg-RX-API-DMAC10.html)
DK (1) DK2278880T3 (cg-RX-API-DMAC10.html)
MX (1) MX2010011063A (cg-RX-API-DMAC10.html)
WO (1) WO2009126825A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018297270B2 (en) * 2017-07-06 2024-02-15 Dignity Health Novel treatment for hot flushes
DK3955933T3 (da) 2019-04-15 2024-02-12 Vistagen Therapeutics Inc Behandling af migræne
MX2025014339A (es) * 2023-06-04 2026-02-03 Vistagen Therapeutics Inc Metodo para mejorar el rendimiento cognitivo o psicomotor
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
JP4450435B2 (ja) * 1996-07-23 2010-04-14 フィーリン・ファーマシューティカルズ・インコーポレイテッド Pmsおよび不安の症状を緩和する、vnoにおける神経化学刺激物質としてのステロイド
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
SI3045182T1 (en) * 2005-11-14 2018-08-31 Teva Pharmaceuticals International Gmbh An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Also Published As

Publication number Publication date
BRPI0910637A2 (pt) 2015-07-28
AU2009234159B2 (en) 2013-12-19
KR20110014147A (ko) 2011-02-10
CN102056484A (zh) 2011-05-11
US20090258040A1 (en) 2009-10-15
DK2278880T3 (da) 2012-11-12
US20120108558A1 (en) 2012-05-03
EP2278880B1 (en) 2012-10-10
HK1157142A1 (en) 2012-06-29
US8431559B2 (en) 2013-04-30
WO2009126825A1 (en) 2009-10-15
JP2011518136A (ja) 2011-06-23
CN102056484B (zh) 2014-10-29
EP2278880A1 (en) 2011-02-02
AU2009234159A1 (en) 2009-10-15
KR101602802B1 (ko) 2016-03-11
EP2278880A4 (en) 2011-08-10
JP5524177B2 (ja) 2014-06-18

Similar Documents

Publication Publication Date Title
Kupperman et al. Contemporary therapy of the menopausal syndrome
TWI336255B (en) Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiqinone and a bronchodilating agent
US20060106004A1 (en) Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause
JP2013523683A (ja) アロマターゼ阻害剤およびゲスターゲンを放出する、子宮内膜症を処置するための非経口用剤形
PT1446128E (pt) Utilização de compostos estrogénicos combinados com compostos progestagénicos na terapia hormonal de substituição
AU2009234159B2 (en) Steroid treatment for hot flashes
Burch et al. The psychobiology of human semen.
US9867850B2 (en) Mixture of processed salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in a mammal
AU2020259269B2 (en) Treatment of migraine
US20250312356A1 (en) Treatment of dysmenorrhea
HK1157142B (en) Steroid treatment for hot flashes
RU2123336C1 (ru) Простагландинсодержащий препарат ветеринарного назначения "клатирам"
KR101368003B1 (ko) 사회 공포증의 급성 치료법
LeBlanc Reproduction deduction-Part 2.
HK40068177B (en) Treatment of migraine
HK40068177A (en) Treatment of migraine

Legal Events

Date Code Title Description
FG Grant or registration